Deadline: February 15, 2013 (Letters of Intent)
As part of its mission to find a cure for ulcerative colitis and Crohn’s disease, the Kenneth Rainin Foundation is inviting Letters of Intent for its 2013 Innovator Awards Program for Inflammatory Bowel Disease.
The program supports innovative “out-of-the-box” research projects that are potentially transformative to the foundation’s efforts to diagnose, treat, and/or cure IBD. The program’s key criteria for funding consideration include innovation, strong collaboration, scientific merit, and a high potential for success, as well as projects that, due to their innovative nature, may not be eligible for funding from the National Institutes of Health or other more traditional sources.
The program is open to tenure-track professors (or the equivalent) at all levels from any scientific discipline and from any nonprofit research institution worldwide. Interdisciplinary collaboration is strongly encouraged.
The Innovator Awards provide $100,000 for one year for proof of principle research. Innovator Award recipients who have demonstrated significant research progress are eligible for longer-term support through the KRF Breakthrough Awards Program. Innovator Awardees are evaluated for potential Breakthrough Awards at the end of their initial year of funding. One-page Letters of Intent, which must include the basic idea and the central experiment, will be accepted online at the KRF Web site from January 15 to February 15, 2013. Invited full applications will be due by May 1, 2013.
For complete program information and application instructions, visit the KRF Web site.
Link to Complete RFP